ALA 002
Alternative Names: ALA-002Latest Information Update: 13 Aug 2024
At a glance
- Originator PharmAla Biotech
- Class Amines; Amphetamines; Behavioural disorder therapies; Benzodioxoles; Small molecules
- Mechanism of Action Adrenergic receptor agonists; Central nervous system stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pervasive child development disorders